TrialDiabetes care2008
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Vivian A Fonseca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
81 papers cite itlatest 60 shown
this paperpooled ittrialcites it